First, disclosure. This writer is a close friend of one of the online proponents of Prodex-B, an antiviral drug proposed for testing against Coronavirus Disease 2019 (Covid-19), but rejected by the country’s Food and Drug Administration (FDA) in its public statement on Monday.

Furthermore, one is not a medical expert, but a journalist citing reports available online or provided by Prodex-B proponent Juan Carlos “JC” de los Reyes, whose Health for Life (HFL) clinic commissioned research on the drug last year, along with former Department of Science and Technology (DOST) Secretary Mario Montejo.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details